|3Nov 17, 5:29 PM ET

SYMYX TECHNOLOGIES INC 3

3 · INTERMOLECULAR INC · Filed Nov 17, 2011

Insider Transaction Report

Form 3
Period: 2011-11-17
Holdings
  • Series C Convertible Preferred Stock

    Exercise: $0.00Common Stock (3,598,375 underlying)
  • Series D Convertible Preferred Stock

    Exercise: $0.00Common Stock (270,724 underlying)
  • Series E Convertible Preferred Stock

    Exercise: $0.00Common Stock (99,105 underlying)
Footnotes (3)
  • [F1]Each share of Series C, Series D and Series E Convertible Preferred Stock will automatically convert on a 1-for-2 basis into common stock upon the consummation of the Issuer's initial public offering.
  • [F2]The securities are immediately convertible.
  • [F3]The expiration date is not relevant to the conversion of these securities.

Documents

1 file
  • 3
    a3.xmlPrimary

    3